中國醫療網絡:二零二三年年報
CHINA MED&HCARE: CLARIFICATION ANNOUNCEMENT REGARDING ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
CHINA MED&HCARE To Go Ex-Dividend On May 30th, 2024 With 0.01 HKD Dividend Per Share
March 19th - $CHINA MED&HCARE(00383.HK)$ is trading ex-dividend on May 30th, 2024. Shareholders of record on May 31st, 2024 will receive 0.01 HKD dividend per share on August 2nd, 2024. The ex-div
China Healthcare Network (00383) will pay a final dividend of HK$0.01 per share on August 2
China Medical Network (00383) announced that the company will distribute until 2023 on August 2, 2024...
CHINA MED&HCARE: SUPPLEMENTAL ANNOUNCEMENT
China Medical & HealthCare Group Returns to Profit in 2023 on Higher Revenue
China Medical & HealthCare Group (HKG:0383) returned to a profit of HK$11.3 million, or HK$0.0122 per share, in 2023, from a loss of HK$123.6 million, or HK$0.1694 per share, in 2022, according to a M
China Medical Network Announces 2023 Annual Results Profit attributable to shareholders of HK$11.295 million, turning a year-on-year loss into a profit
China Medical Network (00383) announced its annual results for the year ended December 31, 2023. The Group achieved total revenue of HK$1,572 billion, an increase of 9.35% over the same period last year; profit attributable to company owners was HK$12.95 million; loss attributable to company owners was HK$124 million; basic profit per share of HK$1.22 cents; and plans to distribute a final dividend of HK$1 per share.
China Healthcare Network (00383.HK): Profit attributable to shareholders in 2023 of HK$11.295 million turned a year-on-year loss into profit
Gelonghui, March 17 | China Healthcare Network (00383.HK) announced its annual results for the year ended December 31, 2023. The Group achieved total revenue of HK$1,572 billion during the period, an increase of 9.35% over the previous year; profit attributable to company owners was HK$12.95 million, compared to a loss of HK$124 million due to company owners; basic profit of HK$1.22 cents per share; and plans to pay a final dividend of HK$1 per share.
CHINA MED&HCARE: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
China Medical Network (00383.HK) held a board meeting on March 15 to approve annual results
GLONGHUI March 5 | China Healthcare Network (00383.HK) announced that the company will hold a board meeting on March 15, 2024 (Friday) to approve (among other things) the annual results and publication of the company and its subsidiaries for the year ended 31 December 2023, and consider paying dividends (if any).
CHINA MED&HCARE: DATE OF BOARD MEETING
Gelonghui Announces Selected (Hong Kong Stock) | Yuanda Pharmaceutical (00512.HK) subsidiary plans to further acquire 63% of Chongqing Doptech's shares for 440 million yuan
[Today's Focus] Yuanda Pharmaceutical (00512.HK) subsidiary plans to acquire a further 63% share of Chongqing Doptech Pharmaceutical (00512.HK) for 440 million yuan. Previously, the group subsidiary Xi'an Beilin Pharmaceutical Co., Ltd. signed an equity investment agreement with Chongqing Doptech Pharmaceutical Co., Ltd. (Doptech Pharmaceutical). According to this, Xi'an Beilin will acquire 27% of Chongqing Doptech Pharmaceutical Technology Co., Ltd. for no more than RMB 189.54 million after meeting the relevant conditions agreed in the investment agreement. On January 15, 2024, the buyer and seller reached a second takeover agreement
China Medical Network Fayingxi expects shareholders to account for profit of about HK$11 million to HK$31 million in 11 months
China Medical Network (00383) announced that the Group expects to obtain profit attributable to shareholders in the 11 months ending November 30, 2023, in the estimated range of approximately HK$11 million to HK$31 million, compared with (a) loss for the same period in 2022; and (b) loss of approximately HK$124 million for the year ended 31 December 2022.
China Medical Network (00383.HK) Yingxi: Expected profit attributable to shareholders for the first 11 months is approximately HK$11 million to HK$31 million
China Medical Network (00383.HK) announced that the company expects to record profit attributable to shareholders in the 11 months ending November 30, 2023, in the estimated range of approximately HK$11 million to HK$31 million, compared with (a) a loss recorded for the same period in 2022; and (b) a loss of approximately HK$120 million for the previous year.
CHINA MED&HCARE: POSITIVE PROFIT ALERT
China Medical & HealthCare Names New Auditor
China Medical & HealthCare Group (HKG:0383) appointed BDO as its auditor, effective Friday, according to a same-dated filing. BDO will take over from RSM Hong Kong, which resigned after not reaching a
China Medical & HealthCare Proposes Name Change
China Medical & HealthCare Group (HKG:0383) proposed to change its name to Tian An Medicare to better reflect its current status and future development, according to a Thursday disclosure. The proposa
China Medical Network (00383.HK) plans to change its name to “Tianan Zhuojian”
Gelonghui, December 14|China Medical Network (00383.HK) announced that the board of directors proposed changing the company's English name and dual foreign Chinese name from “China Medical & Healthcare Group Limited” and “China Medical Network Limited” to “Tian An Medicare Limited” and “Tianan Zhuojian Co., Ltd.” respectively.
China Healthcare Network Announces Li Chenghui Appointed as Non-Executive Director
China Medical Network (00383) announced that since October 10, 2023, Li Chenghui has been appointed as the company's non-executive director and chairman; Wang Dajun has been appointed as a non-executive director of the company, a member of the Company's Remuneration Committee and the Environmental, Social and Governance Committee, and the Chairman of the Investment Committee; Lai Xianrong has resigned as the company's non-executive director; and Jiang Muxian has been appointed as the company's nomination committee and executive committee chairman.
China Healthcare Network (00383.HK) appoints Li Chenghui as non-executive director and chairman
Glonghui, Oct. 10, 丨 China Healthcare Network (00383.HK) announced that it will be effective from October 10, 2023: (i) Mr. Li Chenghui has been appointed as the company's non-executive director and chairman; (ii) Mr. Wang Dajun has been appointed as the company's non-executive director, member of the Company Remuneration Committee and the Environmental, Social and Governance Committee, and Chairman of the Investment Committee; (iii) Mr. Lai Xianrong has resigned as the company's non-executive director; and (iv) Mr. Jiang Muxian has been appointed as the company's nomination committee and executive committee's respective chairman.
No Data